Sign up
Quantellect · Congress · Trade Detail
PINK: CSPCYCSPC Pharmaceutical Group Limited
DemocratHouse

Josh Gottheimer sold CSPC Pharmaceutical Group Limited (PINK: CSPCY)

Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 11 trades in CSPC Pharmaceutical Group Limited (CSPCY) since 2021, 6 purchases and 5 sales, worth an estimated $88K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of CSPC Pharmaceutical Group Limited (PINK: CSPCY) on December 9, 2021. Since that trade, CSPCY is up +18.60% against the S&P 500 up +66.40%, an outperformance of -47.80%.

Across these filings, Josh Gottheimer has been a net buyer of CSPCY (a buy-to-sell ratio of 1.20). The most recent disclosed CSPCY transaction shown was dated September 15, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CSPCY trades
11
Disclosed Vol
$88K
Buys
6
55%
Sells
5
45%
Buy / Sell
1.20
ratio
First → Last
2021–2023

Josh Gottheimer's CSPCY trades vs the price

CSPCY is up +18.60% since Josh Gottheimer sold on December 9, 2021, versus +66.40% for the S&P 500.

Performance since this trade

Price change since trade
+18.60%
S&P 500 change since trade
+66.40%
Outperformance vs S&P 500
-47.80%

All Josh Gottheimer CSPCY trades

TradedTypeSizeReturnEst. profit
September 15, 2023SELL$2.71+63.17%
July 14, 2023BUY$2.88+53.58%+$3K
June 13, 2023SELL$3.01+47.15%
December 30, 2022SELL$3.62+22.46%
April 19, 2022BUY$3.62+22.49%+$472
March 15, 2022SELL$3.37+31.38%
January 10, 2022BUY$4.14+6.97%-$601
December 9, 2021SELL$3.74+18.60%
September 17, 2021BUY$4.26+3.93%-$811
April 15, 2021BUY$4.30+3.14%-$982

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Josh Gottheimer & CSPCY trading FAQ

Is it legal for Josh Gottheimer to trade CSPC Pharmaceutical Group Limited (CSPCY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including CSPC Pharmaceutical Group Limited (CSPCY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Josh Gottheimer sell CSPCY?

Josh Gottheimer disclosed a sale of $1,001 - $15,000 of CSPC Pharmaceutical Group Limited (CSPCY) on December 9, 2021, according to public STOCK Act filings.

How has CSPCY performed since Josh Gottheimer's trade?

Since Josh Gottheimer sold CSPCY on December 9, 2021, the stock is up +18.60%, versus +66.40% for the S&P 500 over the same period, an outperformance of -47.80%.

How many times has Josh Gottheimer traded CSPCY?

Josh Gottheimer has disclosed 11 CSPCY trades since 2021 (6 purchases and 5 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CSPCY trades?

Quantellect tracks every disclosed congressional trade in CSPC Pharmaceutical Group Limited (CSPCY) on the CSPC Pharmaceutical Group Limited congressional trading page, which aggregates filings across all members of Congress.

Josh Gottheimer's CSPCY tradesAll congressional filings for CSPC Pharmaceutical Group LimitedJosh Gottheimer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.